Navigation Links
InVivo Therapeutics and The Miami Project to Cure Paralysis Form Strategic Research Collaboration to Develop Novel Treatments for Spinal Cord Injuries
Date:5/4/2011

CAMBRIDGE, Mass., May 4, 2011 /PRNewswire/ -- InVivo Therapeutics (OTCBB: NVIV), a company focused on the development of groundbreaking technologies for the treatment of spinal cord injuries (SCI), and The University of Miami Miller School of Medicine's Miami Project to Cure Paralysis, the world's most comprehensive spinal cord injury research center, today announced a strategic research collaboration for the development of novel SCI treatments.

The collaboration will evaluate InVivo's biopolymer devices synergistically combined with cellular therapies, including The Miami Project's Schwann cell technologies. Key components of the research collaboration agreement include:

  • in vitro and in vivo studies with combinations of biomaterials, Schwann cells and other cellular therapies and drugs
  • joint ownership of resulting intellectual property
  • right of first offer for InVivo to license and commercialize on a worldwide exclusive basis

  • "This collaboration provides a tremendous opportunity for our technology platform," said Frank Reynolds, CEO of InVivo Therapeutics. "To date, InVivo has been focused primarily on acute spinal cord injury research, and this partnership, which comes shortly before we file an Investigational Device Exemption for our first acute technology, will allow us to advance these technologies to the chronic spinal cord injury population with the Miami Project.  The leadership of Nick and Marc Buoniconti has helped form what has become the world's preeminent center of excellence for SCI research.  We are honored to have them behind our efforts at InVivo and look forward to tapping their expertise to help us with our products," said Frank Reynolds, CEO of InVivo Therapeutics.

    InVivo's biopolymer scaffoldings mimic the natural and protective properties of the extracellular matrix within the spinal cord to promote the proliferation and survival of implanted cells. In preclinical studies
    '/>"/>

    SOURCE The Miami Project; InVivo Therapeutics
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4

    Related biology technology :

    1. invivodata and PRO Consulting to Present at International Industry Events
    2. invivodata Announces ePROficiency 2009 Web Seminar Series
    3. Quintiles Selects invivodata as Primary Partner for ePRO Solutions; Collaboration to Enhance Value, Effectiveness and Speed in Drug Development
    4. invivodata Opens Registration for 3rd Annual Patient Reported Outcomes Conference
    5. INC Research and invivodata Announce ePRO Partnership
    6. invivodata Offers Complimentary PRO Gap Analysis
    7. invivodata Delivers Critical Symptom Relief Data in INSYS Therapeutics' Breakthrough Cancer Pain Trial
    8. invivodata Expands Spring Educational Program
    9. Halozyme Therapeutics Reports 2008 Second Quarter Financial Results
    10. Repair Stem Cell Institute Announces Industrys First Standards of Excellence for Global Stem Cell Treatment Centers to Protect Patients from Less-than-Competent Therapeutics
    11. Amsterdam Molecular Therapeutics Reports Half Year Results 2008
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/5/2015)... The Alliance for Clinical Research Excellence and Safety ... public interest, and Texas-based for-profit San Antonio Express-News ... formed a strategic alliance to create a blog as ... healthcare and clinical research endeavor. The blog provides ... public to be clearly heard in this important dialogue. ...
    (Date:5/4/2015)... SAN FRANCISCO, Calif. , May 4, 2015 ... clinical-stage biopharmaceutical company focused on the development and ... diseases, announced today the completion of its merger ... 4). In conjunction with the closing of the ... from a combination of new investors and all ...
    (Date:5/4/2015)...   St. Jude Children,s Research Hospital ... for finding genetic alterations that play an important ... identify with whole-genome sequencing. The findings appear today ... The tool is an algorithm called ... Tree in Next Generation Sequencing. ...
    (Date:5/4/2015)... 2015  Tikcro Technologies Ltd. (OTCQB: TIKRF) announced today ... 20-F for the fiscal year ended December 31, 2014 ... annual report on Form 20-F contains information regarding its ... area of cancer immune checkpoints. This project aims to ... and binding in targeting certain identified immune checkpoints. The ...
    Breaking Biology Technology:ACRES and San Antonio Express-News Launch Blog on Accountability in Clinical Research 2ACRES and San Antonio Express-News Launch Blog on Accountability in Clinical Research 3ACRES and San Antonio Express-News Launch Blog on Accountability in Clinical Research 4Tobira Therapeutics Completes Financing and Merger with Regado Biosciences 2Tobira Therapeutics Completes Financing and Merger with Regado Biosciences 3Tobira Therapeutics Completes Financing and Merger with Regado Biosciences 4Tobira Therapeutics Completes Financing and Merger with Regado Biosciences 5Tobira Therapeutics Completes Financing and Merger with Regado Biosciences 6Scientists dramatically improve method for finding common genetic alterations in tumors 2Scientists dramatically improve method for finding common genetic alterations in tumors 3Scientists dramatically improve method for finding common genetic alterations in tumors 4Tikcro Technologies Files Annual Report on Form 20-F for the Year Ended December 31, 2014 2
    ... Fla., Oct. 6 Cryo-Cell International, a global leader ... progress in the fight against breast cancer through research ... In honor of National Breast Cancer Awareness Month, Cryo-Cell ... C,elle®, the company,s service which enables women to collect ...
    ... MELBOURNE, Australia, Oct. 5 Cytopia Limited (ASX: CYT) ... BioSciences Inc. ("YM") have signed an exclusive and binding ... YM will acquire all of the issued shares and ... scheme(s) of arrangement ("Scheme(s)") and shareholders (and optionholders if ...
    ... 5 , - Data Presented ... York , ThromboGenics NV (Euronext Brussels: ... innovative medicines for eye,disease, vascular disease and cancer, today announces ... the treatment of,Diabetic Macular Edema (MIVI II DME). The data ...
    Cached Biology Technology:Cryo-Cell International's Stem Cell Research and Development Helps the Fight Against Breast Cancer 2Cryo-Cell International's Stem Cell Research and Development Helps the Fight Against Breast Cancer 3Cytopia Merger with Toronto-based YM BioSciences Inc. 2Cytopia Merger with Toronto-based YM BioSciences Inc. 3Cytopia Merger with Toronto-based YM BioSciences Inc. 4Cytopia Merger with Toronto-based YM BioSciences Inc. 5Cytopia Merger with Toronto-based YM BioSciences Inc. 6Cytopia Merger with Toronto-based YM BioSciences Inc. 7ThromboGenics Announces Results From a Phase IIa Trial Evaluating Microplasmin for the Treatment of Diabetic Macular Edema (MIVI II DME) 2ThromboGenics Announces Results From a Phase IIa Trial Evaluating Microplasmin for the Treatment of Diabetic Macular Edema (MIVI II DME) 3ThromboGenics Announces Results From a Phase IIa Trial Evaluating Microplasmin for the Treatment of Diabetic Macular Edema (MIVI II DME) 4
    (Date:4/27/2015)... -- For more than four decades, AUVSI,s Unmanned Systems ... worldwide event for the unmanned land, sea, and air ... any local, national, or trade news organization interested in ... current applications of unmanned technologies. The conference will explore ... industry, and how it will soon impact the lives ...
    (Date:4/27/2015)... 2015 Profile Solutions, Inc. (OTC: PSIQ), a ... is pleased to announce that Dr Gerry Bedore ... member of its scientific advisory board. ... thought leader in technology-enhanced learning models. He was a ... published studies and books focused on online student success ...
    (Date:4/20/2015)... 2015 Huntington Memorial Hospital is the first ... new miniaturized, wireless monitoring sensor to manage heart failure ... only FDA-approved heart failure monitoring device that has been ... physicians to manage heart failure. The CardioMEMS ... the pulmonary artery (PA) during a non-surgical procedure to ...
    Breaking Biology News(10 mins):UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 2UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 3UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 4UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 5Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 2Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 3Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 4Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 2Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 3
    ... plant life will not be able to "store" excess ... as scientists once thought because plants likely cannot get ... levels of carbon dioxide, according to scientists publishing in ... in turn, is likely to dampen the ability of ...
    ... researchers, led by investigators at Washington University School of ... variant for a bitter-taste receptor on the tongue is ... team studied DNA samples from 262 families, all of ... are participating in a national study called the Collaborative ...
    ... Center shows that on a biochemical level, hormone-like molecules ... way in which certain hormones work in humans ?findings ... afflict a third of the world's population. , UT ... involved in the development and reproduction of Caenorhabditis elegans, ...
    Cached Biology News:Higher carbon dioxide, lack of nitrogen limit plant growth 2Variation in bitter-taste receptor gene increases risk for alcoholism 2Worm hormone discovery may aid fight against parasitic disease 2Worm hormone discovery may aid fight against parasitic disease 3
    ... The Z-Competent E. coli Transformation Buffer Set ... competent E. coli cells for simple and ... completely eliminates the requirement for heat shocking ... can be performed by adding DNA to ...
    ... The Light Diagnostics Universal Amplicon ... for use in the qualitative ... generated by in vitro ... use only; not to be ...
    Propidium Iodide: {3,8-diamino-5-[3-(diethylmethylammonio)propyl]-6-phenylphenanthridinium diodide}. Antifade Solution: p-Phenylenediamine and glycerol in PBS solution. 2.5ug/mL Propidium Iodide (PI)...
    Apoptosis Detection Systems and Reagents...
    Biology Products: